Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Karen Kranda"'
Autor:
Cynthia Helsabeck, Steven K. Libutti, James F. Pingpank, H. Richard Alexander, David L. Bartlett, Tatiana Beresnev, Karen Kranda
Publikováno v:
Cancer. 95:730-736
BACKGROUND Many patients with colorectal carcinoma develop unresectable metastases confined to the liver that remain the life-limiting component of disease despite best available systemic or regional chemotherapy. In the current study, the authors pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5795f0cdc3bfcc279ba9d600d87dcf
https://doi.org/10.1002/cncr.10686
https://doi.org/10.1002/cncr.10686
Autor:
Stephen L. Bacharach, David L. Bartlett, William C. Eckelman, Ronald D. Neumann, Peter L. Choyke, Millie Whatley, H. Richard Alexander, Frederic Jousse, Jorge A. Carrasquillo, Steven K. Libutti, Karen Kranda
Publikováno v:
Annals of Surgical Oncology. 8:779-786
Background An increasing carcinoembryonic antigen (CEA) level in the absence of disease on imaging studies can present a diagnostic challenge. We evaluated 2-[18F] fluoro-2-deoxy-D-glucose and positron emission tomography (FDG-PET) scan and CEA scan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d92a1c0f632d8f6a683d35529a6834c
https://doi.org/10.1007/s10434-001-0779-9
https://doi.org/10.1007/s10434-001-0779-9
Publikováno v:
Annals of Surgical Oncology. 4:215-222
We analyzed morbidity and mortality, sites of recurrence, and possible prognostic factors in 95 (78 male, 17 female) patients with MPM on phase I-III trials since 1990. A debulking resection to a requisite, residual tumor thickness ofor = 5 mm was re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::687a081b73830b61f9480f334a5bb6fc
https://doi.org/10.1007/bf02306613
https://doi.org/10.1007/bf02306613
Autor:
Karen Kranda, Daphne J. Y. Mew, Harvey I. Pass, Jessica S. Donington, Barbara K. Temeck, Steven A. Rosenberg
Publikováno v:
The Annals of Thoracic Surgery. 61:1609-1617
Background A phase I trial was initiated to define the feasibility and safety of single-lung isolation perfusion with tumor necrosis factor- α , interferon- γ , and moderate hyperthermia for patients with unresectable pulmonary metastases. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7163bdd0fd9302dcbe3bfe5478fe68a
https://doi.org/10.1016/0003-4975(96)00166-x
https://doi.org/10.1016/0003-4975(96)00166-x
Autor:
H. Richard Alexander, Lee S. Weinstein, J. Andrea McCart, Steven K. Libutti, Murray F. Brennan, Karen Kranda, Jeffrey A. Norton, William F. Simonds, Arpana Naik, Monica C. Skarulis, Maryann H. Kivlen, Robert T. Jensen, Douglas L. Fraker, David L. Bartlett, Stephen J. Marx
Publikováno v:
Surgery. 130(6)
Background. Patients with multiple endocrine neoplasia type 1 and hyperparathyroidism often undergo multiple operations because of inadequate initial surgery, presence of supernumerary and ectopic glands, regrowth of remnant glands, or autograft hype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5cce756054ddeac9d4889e80c8e21c
https://pubmed.ncbi.nlm.nih.gov/11742328
https://pubmed.ncbi.nlm.nih.gov/11742328
Autor:
Andrew L. Feldman, David L. Bartlett, Steven K. Libutti, Karen Kranda, H. Richard Alexander, Nick G. Costouros, Marshall Miller, Peter L. Choyke
Publikováno v:
Annals of surgical oncology. 8(9)
Background: Circulating inhibitors of angiogenesis have been suggested to affect the growth of distant micrometastatic disease in patients with cancer. This study was designed to evaluate circulating endostatin levels in colorectal cancer patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae80f9adec6b2bf05c2be579269a1b7
https://pubmed.ncbi.nlm.nih.gov/11597016
https://pubmed.ncbi.nlm.nih.gov/11597016
Autor:
Steven K. Libutti, David L. Bartlett, Karen Kranda, H. Richard Alexander, Bernard J. Park, Dan Royalty, Peter Wu
Publikováno v:
Annals of surgical oncology. 6(6)
Primary peritoneal mesothelioma is a locally aggressive disease that is difficult to treat or even palliate. Continuous hyperthermic peritoneal perfusion (CHPP) with cisplatin (CDDP) allows uniform, high regional delivery of chemotherapeutics and hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20df25584b5a514c941a52b7c9582742
https://pubmed.ncbi.nlm.nih.gov/10493628
https://pubmed.ncbi.nlm.nih.gov/10493628
Publikováno v:
Annals of surgical oncology. 2(3)
The treatment of malignant pleural mesothelioma (MPM) continues to be inadequate with the use of standard techniques, including surgery, radiotherapy and chemotherapy. We initiated a phase II trial of immunochemotherapy with cisplatinum (25 mg/m2 fou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecded8642d6aaa374e8f97e60848f5ce
https://pubmed.ncbi.nlm.nih.gov/7641017
https://pubmed.ncbi.nlm.nih.gov/7641017
Autor:
Steven A. Rosenberg, Clara J. Witt, William D. Travis, Harvey I. Pass, Karen Kranda, Helen W. Pogrebniak, Richard Terrill
Publikováno v:
The Annals of thoracic surgery. 57(6)
Isolated lung perfusion with tumor necrosis factor (TNF) potentially could deliver high doses of drug and avoid systemic toxicity in patients with unresectable lung cancer or metastases. We investigated the feasibility of isolated lung perfusion with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1b1763efd11df466ac117a144335f3
https://pubmed.ncbi.nlm.nih.gov/8010790
https://pubmed.ncbi.nlm.nih.gov/8010790
Publikováno v:
Lung Cancer. 15:277
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cb058993416cff314bf6ccc06d35067
https://doi.org/10.1016/0169-5002(96)81648-5
https://doi.org/10.1016/0169-5002(96)81648-5